Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Bibliografische gegevens
Hoofdauteur:	Hoque, Ismoth Ara
Andere auteurs:	Azam, Faruque
Formaat:	Thesis
Taal:	English
Gepubliceerd in:	Brac University 2024
Onderwerpen:	Lung cancer PFS ORR NSCLC subtypes Lungs > Cancer Clinical trials > Statistical methods
Online toegang:	http://hdl.handle.net/10361/23164

Gelijkaardige items

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
door: Paul, Pulock
Gepubliceerd in: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
door: Rahman, Tasnim
Gepubliceerd in: (2024)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
door: Karim, Samia Binte
Gepubliceerd in: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
door: Flora, Sanzida Alam
Gepubliceerd in: (2024)

Molecules associated with the development of lung cancer
door: Rahman, Adree, et al.
Gepubliceerd in: (2023)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
door: Das, Reshita
Gepubliceerd in: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
door: Jeba, Joynob
Gepubliceerd in: (2017)

A review on targeted therapies for lung cancer
door: Ashraf, Anushey
Gepubliceerd in: (2023)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
door: Razna, Amrin Islam
Gepubliceerd in: (2019)

Potential of liposomes for the treatment of lung cancer- a review
door: Mim, Shanzida
Gepubliceerd in: (2023)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
door: Tania, Umme
Gepubliceerd in: (2023)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
door: Zangmo, Thinley
Gepubliceerd in: (2024)

A review on recent advances in drugs for lung cancer treatment
door: Noor, Fouzia
Gepubliceerd in: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
door: Pial, Sazia Afrin
Gepubliceerd in: (2018)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
door: Shabnam, Musharrat
Gepubliceerd in: (2018)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
door: Bristy, Israt Zerin
Gepubliceerd in: (2021)

Immunotherapy in the Management of Lung Cancer
door: Tasnim, Humayra
Gepubliceerd in: (2022)

Lung cancer detection and classification using machine learning
door: Arefin, Mahbubul, et al.
Gepubliceerd in: (2023)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
door: Mukti, Roushney Fatima, et al.
Gepubliceerd in: (2016)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
door: Nandy, Aditi
Gepubliceerd in: (2022)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
door: Shobnam, Sohana
Gepubliceerd in: (2024)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
door: Hasan, Sakib
Gepubliceerd in: (2024)

Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis
door: Monayem, Kazi Fahim
Gepubliceerd in: (2024)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
door: Oishy, Jannatun Noor
Gepubliceerd in: (2024)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
door: F. S. Amaral, André, et al.
Gepubliceerd in: (2017)

A comparative study of lung cancer prediction using deep learning
door: Mugdho, Aka Mohammad, et al.
Gepubliceerd in: (2023)

Semantic segmentation with attention dense U-net for lung extraction from X-ray images
door: Auvy, Akib Al Mahmud, et al.
Gepubliceerd in: (2023)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
door: Hossain, Safa Binte
Gepubliceerd in: (2019)

Deep 3D convolutional neural network in early detection of Lung cancer
door: Hossain, Khandoker Jobayer, et al.
Gepubliceerd in: (2019)

Statistics and informatics in molecular cancer research

Smart biomedical device to predict lung diseases, COVID-19 and diabetes by using machine learning algorithms
door: Hossain, Ashraful, et al.
Gepubliceerd in: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
door: Hasan, Amit
Gepubliceerd in: (2024)

Machine learning as an indicator for breast cancer prediction
door: Shadman, Tahsin Mohammed, et al.
Gepubliceerd in: (2019)

The uses of bacteria in cancer therapy
door: Saha, Shimul, et al.
Gepubliceerd in: (2021)

Safety and efficacy of cisplatin combinations with vinorelbine, paclitaxel and gemcitabine – a systematic review and meta-analysis
door: Islam, Inaya
Gepubliceerd in: (2024)

Cancer risk factors: a critical review
door: Tabassum, Tahsina
Gepubliceerd in: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
door: Nawar, Anika
Gepubliceerd in: (2019)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
door: Abir, Shifaty Nur
Gepubliceerd in: (2024)

Targeting BRAFV600E in the treatment of CRC
door: Roja, Mashwiyat Samrin
Gepubliceerd in: (2024)

The impact of cell penetrating peptides in prospective cancer therapy: a review
door: Nashrah, Zannatul
Gepubliceerd in: (2023)